As a leading provider of nitinol components and services, ÃÛÌÒ´«Ã½ participated in the 2024 SMST conference. The program was heavily focused on the latest research and development in nitinol, with ÃÛÌÒ´«Ã½ among other industry leaders presenting their work. Kevin Kelly, CEO of ÃÛÌÒ´«Ã½, emphasized that this scientific focus is crucial for continuing to push the boundaries of what’s possible with nitinol, particularly in the growing medical device market.